EY Biotech Beyond Borders Report 2025 | EY - US
Biotech companies and life sciences leaders are managing uncertainty and preparing to bounce back across the biotechnology landscape. Find out how.| www.ey.com
Biotech companies and life sciences leaders are managing uncertainty and preparing to bounce back across the biotechnology landscape. Find out how.| www.ey.com
Pharma market growth forecasts and drug sales to 2030 reflect solid underlying demand. But much is changing across the biopharma landscape.| Evaluate
Evaluate’s custom analytics team help you to address unique commercial challenges. We answer key asset, portfolio, and corporate strategy-related questions, powered by the combined resources of Norstella.| Evaluate
Utilize Evaluate for Market Opportunity Sizing to gain comprehensive insights into the potential clinical and commercial differentiation of new assets, their competitive landscape, and the market dynamics.| Evaluate
